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Recognition ofclinical syndromes in returned travelers is an important part ofproviding care
to international travelers. The first step is to take a history with attention to pre-travel
preventive measures, the patient's itinerary, and potential exposure to infectious agents. The
patientshould thenbeexamined todocumentphysicalsigns,such asfever, rash, orhepatospleno-
megaly, and to have basiclaboratory dataobtained. This evaluation will provide most physicians
with the necessary information to generate a differential diagnosis. Each diagnosis should be
matched against the incubation period of the disease, the geographic location of illness, the
frequency of illness in returned travelers, and the pre-travel preventive measures. Careful
attention to these aspects of patient care should result in the appropriate diagnosis and
therapeutic intervention for the ill returned traveler.
The preparation oftravelers for a trip to the developing world has been the major
focus of travel medicine [1,2]. Discussion of malaria prophylaxis, diarrhea preven-
tion, and provision of immunizations for protection against vaccine-preventable
diseases takes up the majority of the pre-travel physician visit. If the traveler
completes the trip without anything more than a mild case oftravelers' diarrhea, the
traveler and the physician often feel that they are "home free." Many illnesses,
however, may occur after return home, and it is critical that both the patient and the
physician make the possible association ofillnesswith a trip to the developingworld.
This paper will provide an approach to evaluating the returned traveler for medical
illness and discuss major clinical syndromes.
WHO SHOULD BE EVALUATED?
While strict criteria cannot be developed for deciding which travelers to evaluate,
there are three groups forwhom a physicianvisit maybe helpful. The first comprises
those who have had prolonged residence in the developing world. A somewhat
arbitrary duration of residence is six or more months. These individuals are likely to
have an increased cumulative risk of exposure to infectious agents, particularly
intestinal helminths. Asecond groupconsistsofthose travelerswho had, duringtheir
trips, illness which was more extensive than a mild case of travelers' diarrhea or
upper respiratory tract infection. Finally, any traveler who exhibits symptoms within
several weeks ofreturn, and occasionally up to months and years after return, should
be seen.
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TABLE 1
Evaluation of the Returned Traveler: Historical Features
Pre-travel care
Immunizations
Malaria prophylaxis
Other preparations
Reason for travel
Itinerary
Countries visited
Urban versus rural travel
Length of stay
Exposure risk
Illness in fellow travelers
Predominant symptom
PATIENT EVALUATION
The evaluation of the returned traveler includes a careful history, targeted
physical exam, and selected laboratory testing. At each level of evaluation, the
physician should bear in mind the fact that many illnesses in the returned traveler
may be completely unrelated to the patient's travel.
HistoricalFeatures
The history begins with preparations taken before the trip (Table 1). Which
immunizations were administered? Which prophylactic medication for malaria was
prescribed? Was the patient compliant with the antimalarial? Were additional
preventive measures taken? The excellent efficacy ofyellow fevervaccine essentially
excludes the diagnosis ofyellow fever in the immunized traveler. Typhoid immuniza-
tion may only be 50 to 70 percent effective, however, making a diagnosis of typhoid
fever still possible in someone with abdominal discomfort, malaise, and sustained
fever. While the preventive efficacy ofmalaria prophylaxis maybe excellent for some
areas of the world, such as Central America, Mexico, and the Caribbean, the
emergence of resistant forms ofPlasmodiumfalciparum throughout most of the rest
of the world dictates that malaria should always be part of the differential diagnosis
of a febrile illness.
The next important historical feature is to determine the reason for the trip, its
duration, the itinerary, and whether rural areas were visited. Those who travel to
Nairobi, Kenya, for a week on a business trip have a much lower risk of disease
acquisition than the expatriate missionary who has lived in rural Kenya for many
years. With a longer duration of travel, the incidence of many diseases such as
hepatitis A, typhoid fever, and intestinal parasites increases, and it becomes more
likely that the traveler will have acquired an infection endemic to nationals [3,4].
The next goal is to determine the traveler's risk of exposure to disease. Did the
individual swim in fresh water in an area endemic for schistosomiasis? Ifthe traveler
did not, schistosomiasis will not be in the differential of eosinophilia. Did the
individual walk barefoot in areas where the larvae of hookworm or strongyloides
could penetrate the skin? Did the traveler ingest raw milk orcheese, drink tapwater,
or eat food purchased from street vendors? Not following care in food and liquid
sanitation will increase the risk for enteric bacterial and parasitic disease. Did the
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TABLE 2
Physical Exam ofthe Returned Traveler
Screening exam for all travelers:
Vital signs
Skin
Lymphatics
Heart and lungs
Liver and spleen size
traveler have known exposure to insect vectors, such as mosquitos for malaria or
black flies for onchocerciasis? Did the individual engage in high-risk sexual behavior,
placing himself or herself at risk for sexually transmitted diseases and HIV or
hepatitis B infection?
Finally, the physician needs to assess carefully the patient's description of the
illness in order to determine what is the predominant complaint or symptom. Is it
abdominal pain, diarrhea, fever, lymph gland swelling, skin rash, or respiratory tract
illness? Determination of the predominant symptom will narrow the differential
diagnosis and help in targeting the laboratory investigation. Because some illness
may occur in clusters, it is helpful to ask ifthere was similar illness in fellow travelers
[5,6].
PhysicalExam
The physical exam ranges from a screening exam for the healthy returned traveler,
to an in-depth exam which focuses on the chief complaints in the ill traveler (Table
2). The minimal exam for all travelers should include vital signs, examination ofthe
skin for rashes or insect bites and the lymphatics for swelling, auscultation of the
heart and lungs, and palpation of the abdomen, specifically to elicit abdominal
discomfort and to assess the size of the liver and spleen. If the patient has been
febrile, it is helpful to have the individual bring in a record of temperature to
determine the feverpattern. Amore detailed exam shouldbeperformed asappropri-
ate and directed toward the specific historical features. For example, if there has
been sexual contact, a careful genital exam should be done.
Laboratory Testing
The predominant symptoms and signs that have been elicited from the patient, in
addition to the exposure history, will help to direct the laboratory investigation.
There are two levels of investigation that are appropriate (Table 3). The first level
consists of tests which will give the highest yield, based on the most likely diagnoses
in the returned traveler. The second level includes those tests which are either more
invasive or those which should be delayed until after preliminary information has
been obtained. All patients who have had either prolonged residence in the develop-
ingworld, or exposure to personswithpossible tuberculosis, should receive apurified
protein derivative (PPD) skin test approximately two months after return [2].
Initial laboratory tests may include a complete blood count, stool for culture and
parasite exam, serum electrolytes, creatinine, and liver enzymes. If the patient is
febrile, a thick and thin malaria smear should be done. If there are respiratory
complaints, a chest X-ray may be helpful in order to rule out pneumonia or cavitary
lesions.
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TABLE 3
Laboratory Testing of the Returned Traveler
Initial "screening" tests:
Complete blood count
Blood smear for malaria parasites
Liver enzymes
Electrolytes; creatinine
Urine analysis
Stool culture, ova and parasite exam
Acute phase serum
Secondary tests:
PPD
Sputum exam and culture
Chest X-ray
Blood and bone marrow cultures
Hepatitis serology
Syphilis and HIV testing
Lumbar puncture
Endoscopy
Intravenous pyelogram
Ultrasound; CT/MRI scanning
Tissue biopsy
Although many of these laboratory tests are not diagnostic of a specific disease,
they can guide further testing and help to exclude or include diseases in the
differential diagnosis. As examples, the complete blood count suggests a bacterial
infection if there is a leukocytosis with a left shift, or a viral infection if there is
leukopenia. Anemia could indicate a chronic disease process unrelated to travel;
however, if the anemia is hemolytic, one should rule out malaria, or a drug reaction
such as can occur in individuals taking primaquine phosphate who have glucose-6-
phosphate dehydrogenase deficiency. If the anemia is secondary to iron deficiency,
chronic intestinal blood loss from hookworm infestation should be ruled out.
Thrombocytopenia can be seenwith arboviral infections such as dengue fever orwith
malaria. Eosinophilia will be discussed in a later section, but it suggests a helminthic
infection, either in the gastrointestinal tract, such as hookworm, or in the tissues of
the patient, such asvisceral larvae migrans or schistosomiasis.
Elevation of liver enzymes is also nonspecific and is a frequent finding in many
systemic viral and bacterial infections. The degree of enzyme elevation may be
helpful, however, with severe hepatocellular necrosis usually indicating infection
with specific hepatic viruses such as hepatitis A, B, or non-A, non-B (now known as
hepatitis C).
A stool culture and ova and parasite exam is particularly helpful in assessing
infection with an enteric bacterial agent or parasite. For many protozoal infections,
such as giardiasis and amoebiasis, three separate stools examined over several days
may be necessary to obtain the maximum yield [7]. A stool ova and parasite exam
should also be considered for an asymptomatic returned traveler who resided in the
developing world for a prolonged time. If this traveler harbored an intestinal
parasite, many clinicians would elect to treat the patient, especially if the individual
were not planning to return to the place ofexposure in the developingworld.
Finally, it is frequently helpful to draw and save an acute phase serum, which can
346EVALUATION OF THE RETURNED TRAVELER
be sent to a reference laboratory or the Centersfor Disease Control to establish or to
confirm a diagnosis. Serologic testing for many ofthe arboviral infections is particu-
larly helpful, since viral isolation is not routinely available. For parasitic serodiagno-
sis, there is awide range ofsensitivity and specificity, and testswill frequently remain
positive long after clinical resolution of illness and, therefore, not be able to
distinguish current from past infection [8]. Nevertheless, for some infections inwhich
actual demonstration of the parasite may be difficult, serodiagnosis can help to
establish the diagnosis. These diseases include toxoplasmosis, trichinosis, echinococ-
cosis, amoebic liver abscess (positive in over 95 percent of cases), Chagas' disease,
leishmaniasis, and filarial infection. Much of the future testing for tropical diseases
will include detection ofantigens in the appropriate tissue orbody fluid specimen.
The second level of laboratory testing is needed when initial investigations either
fail to yield a diagnosis or more information is needed. These tests include a sputum
exam and culture or, occasionally, an ova and parasite exam of sputum for paragon-
imiasis ifthere are respiratory complaints and an abnormality on chest X-ray. Blood
or bone marrow cultures may be required to rule out enteric fever or to detect
parasites invisceral leishmaniasis. Specificserology forhepatitis A, B, or C should be
done when there is a compatible history and laboratory tests consistent with
hepatitis. HIV testing or syphilis serology should be done when there has been an
appropriate exposure. If the urinalysis is abnormal or reveals eggs, an intravenous
pyelogram or ultrasound can be done in order to assess pathologic changes associ-
ated with Schistosoma haematobium.
For some intestinal conditions, upper endoscopy, barium studies, or colonoscopy
will help to establish an etiology. For instance, when there is malabsorption in a
returning traveler and stool exam for ova and parasites is negative, small bowel
aspiration and/orbiopsy can help to detect tropical sprue, Giardia, strongyloides, or
cryptosporidium. Colonoscopywith scrapings ofan ulcer maybe helpful in detecting
Entamoeba histolytica, and rectal biopsies in diagnosing schistosomiasis. Abdominal
ultrasonography, CT scanning, or MRI scanning may help to differentiate a solitary
lesion in the liver, which could represent a benign cyst, hepatoma, amoebic liver
abscess, or cyst ofechinococcus.
Patients who present with focal neurologic signs and symptoms could have a
space-occupying lesion, which should be evaluated with CT scanning or MRI. Some
of the lesions which can be demonstrated are cysticerci from larval infection by
Taenia solium, immature worms of Paragonimus westennani, and, rarely, brain
abscesses associated with central nervous system (CNS) migration of the larval
worms of ascaris and strongyloides [9]. Lumbar puncture is helpful in evaluating
travelers presenting with meningitis or meningoencephalitis, and mandatory if
bacterial meningitis is suspected. Eosinophilic meningitis has been associated with
larvae of the rat lungworm, Angiostrongylus cantonensis, and prurulent meningitis
with the free-living amoeba, Naegleria and Acanthamoeba sp. Larvae of Trichinella
spiralis can occasionally be identified in the cerebrospinal fluid (CSF) in cases of
meningoencephalitis secondary to trichinosis. For patients with chronic meningoen-
cephalitis and in whom trypanosomes of African trypanosomiasis have been de-
tected, examination of the CSF is mandatory to document whether or not CNS
involvement has occurred.
Tissue biopsies may also be necessary to establish a diagnosis. The following
procedures may be useful: a lymph node aspirate in African trypanosomiasis,
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TABLE 4
Parameters Used to Evaluate A Potential Diagnosis
Incubation period
Geographic area of risk
Frequency of illness in returned travelers
Pre-travel preventive measures
quadriceps muscle biopsy in trichinosis, rectal biopsy in schistosomiasis, and skin
snips, smears, or biopsies for detection of filarial worms, acid-fast organisms of
leprosy, or amastigotes ofcutaneous leishmaniasis.
GENERATION OF A DIFFERENTIAL DIAGNOSIS
After a careful history, physical exam, and directed laboratory testing, a predomi-
nant clinical syndrome can be described, which will help to narrow the differential
diagnosis. The focus can be on systemic illness such as fever or exanthem, on
organ-specific illness such as diarrhea, jaundice, or hepatosplenomegaly, or on an
isolated laboratory finding such as anemia or eosinophilia. One must alwaysconsider
the possibility that the patient's illness may be unrelated to travel, and, therefore, a
differential diagnosis ofnon-travel-related illness should be generated.
Each potential diagnosis should then be matched against its incubation period, its
geographic area of risk, the frequency of its occurrence in travelers, and the
pre-travel prevention measures (Table 4). One ofthe most helpful parameters is the
incubation period of illness (Table 5). When considering incubation periods, it is
critical to know the exact dates of travel to tropical areas of exposure, since it is not
uncommon that a traveler will add visits to developed, temperate areas at the
beginning or end ofthe trip. Ifa traveler has left the area ofexposure for more than a
few weeks, many diseases can be excluded, because the incubation period for most
arboviral and enteric bacterial infections will have been exceeded. Many parasitic
TABLE 5
Incubation Periods of Illness in the Returned Traveler
Short ( <7-10 Days) Intermediate Long (> 1 Month)
Diarrhea Malaria Malaria
Bacterial Enteric fever Tuberculosis
Viral Giardiasis Viral hepatitis
Bacterial pneumonia Amebiasis Schistosomiasis
Arbovirus infection Brucellosis Amebic liver abscess
Rickettsial disease Leptospirosis Visceral leishmaniasis
STDs Lyme borreliosis Filariasis
Gonorrhea Strongyloidiasis Helminthic infection
Chlamydia Lassa fever Trypanosomiasis
Herpes simplex Trypanosomiasis (gambian)
Ebola/Marburg virus (rhodesian) Tropical sprue
Plague Schistosomiasis (acute) Symptomatic HIV
STDs Rabies
Syphilis
Lymphogranuloma venereum
STDs, sexually transmitted diseasesEVALUATION OF THE RETURNED TRAVELER
TABLE 6
Illness Associated with Travel to the Developing World
Diagnosis Incidencea
Enteric illness:
Travelers' diarrhea 150 to 400
Giardiasis 4 to 10
Amebiasis I to 5
Enteric fever .002 to 0.2
Upper respiratory tract infections 10 to 50
Dermatitis 5 to 20
Hepatitis, all types 1 to 10
Febrile syndromes: 1 to 10
Arboviral
Undiagnosed, self-limited
Sexually transmitted diseases 0.3 to 3
Malaria 0.5 to 2
alncidence per 1,000 travelers; estimates ofincidence include illness
which began during travel as well that which occurred upon return.
Data taken from [2,3,14-17]
infections such as malaria, intestinal protozoa, and intestinal and systemic helminths
can, however, occurweeks to months after return.
Knowledge of the geographic distribution of illness is also important. Although it
is often difficult to obtain accurate information about the prevalence of disease,
several recent resources are helpful in identifying geographic areas of risk for both
common and unusual diseases [2,10-12]. Diseases which are both common and
widely distributed, such as malaria, enteric infections, and arboviral infections, will
account for the majority of illness in returned travelers. When large numbers of
individuals are concentrated in a small geographic area, however, even infrequent
infections can occur, such as the cluster of cases of viscerotropic leishmaniasis in
United States troopswhoparticipated in Operation Desert Storm in the Middle East
[13].
Finally, knowledge ofthe preventive measures taken by the traveler, the efficacyof
the vaccines, and the compliance with prescribed medications will help the physician
in determining risk.
ILLNESS UPON RETURN
Common Syndromes
Fortunatelyfor the traveler, most illnesswhich occurs after return is self-limited or
can be diagnosed and effectively managed. The most common illnesses which occur
both during and followingtravel and theirfrequencyofoccurrence are listed in Table
6 [3,14-17]. While this list is applicable to most travelers, the use of specific
prophylactic measures, such as immune globulin for the prevention ofhepatitis A, or
compliance with antimalarials, can alter the incidence of illness. Table 7 lists the
reported illness in returned travelers who visited the International Traveler's Medi-
cal Service at the University ofConnecticut before their trips [10].
Three major syndromes in the returned traveler are particularly important to
discuss. They are fever, eosinophilia, and diarrhea.
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TABLE 7
Reported Illness Following Travel in 512 Individuals Who Attended a Travel Medicine Service
Symptom Continuationa New Onsetb Total (%)
Any symptom 119 (23)
Diarrhea 15 39 54 (11)
Upper respiratory tract infection 21 22 43 (8)
Skin problem 7 8 15 (3)
Febrile episodes 2 5 7 (1)
Malaria 1 1
Hepatitis non-A, non-B 2
alllness which began during travel and continued on return
bjllness which began after travel
Source: Adapted with permission, from [18]
Fever In the assessment of the febrile traveler, the duration of the fever, its
pattern, and its height can be helpful. Sustained fever is often associated with
typhoid, intermittent fevers with malaria, and a saddle-back fever with dengue. Only
a few illnesses are accompanied by temperatures > 104°F; these include falciparum
malaria, severe bacterial infection, measles, and meningitis.
The most important illness to rule out in the febrile traveler is malaria. Even if
chemoprophylaxis has been used, malaria always must be considered in the differen-
tial diagnosis, since no preventive measure is 100 percent effective. The patient
should be examined, and thick and thin blood smears obtained once or twice daily
until the diagnosis is made. For the most severe form of malaria, Plasmodium
falciparum, 95 percent of cases occur within the first two months after leaving the
endemic area [19]. Plasmodium vivax or, less commonly,P. ovale, may occur at longer
intervals, with 20 percent occurring six or more months after return [19]. Factors
which have been associated with fatal episodes offalciparum malaria include failure
of patients to take chemoprophylaxis during travel, delay in seeking medical atten-
tion (usuallybeyondfourdays after the onset ofsymptoms), failure on the part ofthe
physician to make or consider the diagnosis, and older age (. 70years) [20].
Arboviral infections are a frequent cause of fever in returned travelers. Although
most of these infections are self-limited and require only supportive therapy, they
may cause significant morbidity [21]. Dengue fever is probably the most common of
these and is characterized by fever, chills, retro-orbital headache, malaise, severe
myalgias and back pain, leukopenia, and a fine, maculo-papular, truncal rash [22].
The fever with dengue may have a saddle-back pattern, which is characterized by an
absence or decline in fever between two febrile episodes. Rickettsial infections
should be considered, particularly in those with a systemic rash or an eschar at the
site ofan insect bite [23,24].
Eosinophilia Eosinophilia is another important syndrome in the returned
traveler [25,26]. An elevated eosinophil count is typically indicative of a helminthic
infection, often with tissue invasion. Most protozoal infections do not have elevated
eosinophil counts, although infection with Isospora belli and Toxoplasma gondii can
be exceptions.
The first step is to confirm that the eosinophil count is actually elevated. To
determine the eosinophil count, the total white blood cell count is simply multiplied
by the percentage ofeosinophils. Ifthe number exceeds 500, eosinophilia is present.
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There are several non-infectious, non-travel-related reasons foreosinophilia, such as
environmental or medication allergies, so these need to be considered before
deciding that the eosinophilia is definitely related to travel.
To establish an infectious etiology for eosinophilia, it is helpful to check three
stools for ova and parasites. Occasionally, an ova and parasite exam of urine will be
necessary to exclude Schistosoma haematobium. While stool exams will detect most
helminths which have an intestinal phase to their life cycle, some of the tissue
parasites, such as trichinella, visceral larva migrans, and filariasiswill be missed. If a
stool or urine exam does not yield the diagnosis, a string test for strongyloides,
parasite serology, blood smears for filaria, or skin and tissue biopsies may be
required. If a traveler is being evaluated for eosinophilia soon after return, testing
may need to be repeated after three to six months because of the prolonged time
many filarial or intestinal helminth infections may take to become clinicallymanifest.
Diarrhea Diarrhea is the most frequent reason for which travelers seek medi-
cal care after return [3]. These travelers should be askedwhether the diarrheabegan
during their trips or only after return, and if they took any medications for it. The
nature of their illness should be determined, with particular attention paid to
whether fever, vomiting, severe cramping, blood in the stools, or loss of weight
occurred. Enterotoxigenic Escherichia coli (ETEC) is the most common etiology of
travelers' diarrhea and causes frequent watery bowel movements with cramping,
nausea, and occasionally a low-grade fever [27-29]. Invasive pathogens such as
Shigella, Salmonella, and Campylobacter may cause fever > 101.5°F, uncomfortable
cramping, and occasional blood in the stools [27,30]. One's effort to isolate a
particular bacterial pathogen may be hindered by spontaneous resolution of illness
and clearance ofbacteria, or initiation oftreatmentby the patientwith an antimicro-
bial agent. Nevertheless, the stool should be cultured forpersistent bacteria and also
examined for white blood cells with a methylene blue stain in order to determine if
inflammation secondary to an invasive pathogen is present.
In the case of diarrhea which occurs a week or two after return or persists in spite
of antibiotic therapy, a parasite, such as Giardia lamblia, a resistant bacteria, or
mucosal damage is possible [31,32]. Thus, several stools should be examined for ova
and parasites in addition to bacterial culture. Many of the helminths will not be
documented in the stool until weeks or months after return.
Malabsorption can be diagnosed by assessing the nature of the stool (greasy,
foul-smelling), whetherweight loss is present, and if specific foods are not tolerated,
such as those containing lactose. While small bowel radiography and biopsy may be
helpful to rule out upper intestinal parasites or tropical sprue, these testswill usually
not be necessary. Many travelers who have had an episode of travelers' diarrhea
during their trips develop a post-infectious irritable bowel syndrome. This condition
usually resolves spontaneously over weeks to months, but may be improved by
increasing the bulk of the stool with a synthetic fiber such as Metamucil. Post-
infectious lactose intolerance may also be aproblem and, in manycases,will be a clue
to chronic giardiasis.
Management
After the patient has been seen and evaluated, a management decision must be
made. If a diagnosis has been established, the appropriate therapeutic intervention
can be undertaken on an outpatient basis, or, if illness warrants, the patient may
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need to be admitted. If the diagnosis has not been established and the patient is
stable, observation may be carried out in an outpatient setting with frequent
follow-up, while awaiting the return ofcultures or laboratory testing. Ifthe patient is
at all unstable, it is prudent to admit the individual to the hospital for further
observation and diagnostic testing.
Occasionally it will be necessary to initiate empiric therapy even though one may
not have complete information. Some febrile patients for whom malaria has been
excluded, and the remainder of the diagnostic work-up has not been revealing, will
respond to empiric tetracycline therapy given for a suspected rickettsial infection.
Patients with persistent eosinophilia may harbor strongyloides and will benefit from
a therapeutic trial of thiabendazole [26]. Although most patients in whom Giardia is
the cause of chronic diarrhea will excrete the parasite in the stool, occasionally the
stoolwillbe negative, and anempiric course ofmetronidazole therapywill relieve the
patient's symptoms.
There are a few danger signs or symptomswhich, when reported by the patient or
found on examination orlaboratorytesting, should promptthe physician tointervene
immediately, and usually to admit the patient to the hospital. These include high
fever (. 104°C), dysentery, mental status changes, severe anemia, or hemorrhagic
rash. These signs and symptoms may indicate rapidly progressive or potentially fatal
illness if the patient is not treated promptly. High fever may indicate malaria or
severe bacterial infection. A fever, rash, and bleeding diathesis in a patient, who
presents within two weeks of rural travel to Africa, could indicate one of the
hemorrhagic fevers-Marburg, Ebola virus, or Lassa fever. The patient should be
immediately isolated. Guidelines have recently been developed for managing these
patients [33,34]. Otheretiologies forhemorrhagic rash areyellowfever, meningococ-
cemia, rickettsial disease, and dengue hemorrhagic fever.
CASE ILLUSTRATION
In order to illustrate how the principles discussed in this paper maybe applied to a
returned travelerwho is ill, the following case is presented.
A31-year-old, previouslyhealthywoman presented to the International Traveler's
Medical Service with a four-day history of chills and fever to 103°F. Three weeks
prior to presentation, she had traveled to Haiti to work in rural areas on her
anthropology Ph.D. studies. Prior to hertrip, she wasgiven typhoid and poliomyelitis
immunization and passive prophylaxis with immune globulin. She took chloroquine
phosphate for malaria prophylaxis.
Nineteen days after being in Haiti, she experienced the abrupt onset of severe
retro-orbital headache, nausea, vomiting, diffuse abdominal pain, severe back and
leg myalgias, chills, and fever to 103°F. She took acetaminophen to treat her
symptoms. Because ofpersistent illness, whichconfined her tobed for three days, she
decided to return to the United States. Immediately upon return, she was seen in a
local Emergency Room, in which she was given two liters of intravenous fluids,
compazine suppositories for nausea, and had blood and urine cultures taken. She
was sent home without a diagnosis, but told she might have "hepatitis, typhoid fever,
or parasites."
The next morning she presented to our facility with the above history and
persistent symptoms. In addition, she had no cough, chest pain, dysuria, diarrhea, or
change in skin or urine color. She had been compliant with malaria prophylaxis, and
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TABLE 8
Differential Diagnosis ofFever and Exanthem
Malariaa
Enterovirus
Childhood exanthems:
Measles
Rubella
Arboviral infections:
Dengue
Other
Typhoid fever
Leptospirosis
Rickettsial illness:
Typhus group
Spotted fever group
aAlthough malaria is not associated with a rash, it is included with
the differential ofa febrile illness.
had been careful to avoid untreated liquids and uncooked foods. She had noted
frequent exposure to mosquitoes. On physical exam, she appeared fatigued and
moderately ill. Her temperature was 99.6°F orally, her pulse was 54, and blood
pressure 99/55 without orthostasis. Pertinent physical findings included a faint,
blanching maculopapular rash with a truncal distribution; there were no petechiae.
There was some conjunctival injection but no icterus. She had mild pharyngeal
injection; there was no lymphadenopathy. Her chest was clear, and her heart was
without murmur, gallop, or rub. She had mild, diffuse discomfort on abdominal
exam, without hepatosplenomegaly. Her stool was brown and guaiac-negative.
On laboratory testing, her total white blood cell count was 2.8 with 51 percent
polymorphonuclear cells, 30 percent lymphocytes with some atypical lymphocytes, 7
percent monocytes, 1 percent eosinophils, and 11 percent bands. Her hemoglobin
was 13.3, and her platelet countwas 189,000. Herliver enzymesweremildly elevated,
with a serum aspartate aminotransferase of 66 (normal 17-35), a serum alanine
aminotransferase of 74 (normal 8-37), and a lactate dehydrogenase of 141 (normal
81-175). Her bilirubin and creatinine were 0.5 and 0.6, respectively, and the
urinalysis was normal.
The patient's history, physical exam, and initial laboratory data can be used to
determine the predominant clinical syndrome. Her history revealed an abrupt onset
of fever, severe headache, myalgias and arthralgias, nausea and vomiting. Her
physical exam was notable for conjunctival injection, a truncal rash, and mild
abdominal discomfort. She also had a bradycardia relative to her temperature
elevation. Her laboratory data revealed leukopenia and mildly elevated liver en-
zymes. In distilling the information, she had a fever and exanthem. Table 8 lists the
differential diagnoses. Each of these diagnoses can be examined against the incuba-
tion period, geographic distribution, frequency of occurrence in travelers, and the
pre-travel preventive measures.
The incubation period for her illnesswas short, a fewdays to less than threeweeks,
since she developed her illness while still in Haiti. Table 5 indicates those diseases
with short to intermediate ( <7 to 30 days) incubation periods. Those which can be
associated with fever and rash (Table 8) canbe considered further. Althoughmalaria
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is not associated with a rash, it must always be considered in the differential diagnosis
of a fever in a returned traveler. In Haiti, malaria is caused exclusively by Plasmo-
dium falciparum and remains sensitive to chloroquine phosphate. Although no
malaria preventive is 100 percent effective, she was compliant with her chloroquine,
making the diagnosis of malaria unlikely. Nevertheless, a malaria smear was re-
quired.
Of the viral infections, enteroviruses are distributed widely throughout the world
and are common, but illness is generally not as severe as this woman experienced.
Measles is also widely distributed, but she did not have coryza, and she had received
measles vaccination in childhood and was likely to have been protected. Measles,
however, may rarely occur in vaccinated individuals, particularly young adults. This
observation has led to new recommendations for measles prophylaxis [35,36].
Arboviral infections are frequent, but many of them have a limited geographic
distribution. For example, although her illness of fever, rash, and arthralgias was
compatible with many ofthe African or Far Eastern arboviruses, such as Rift Valley
fever and Chikungunya viruses, her travels did not take her to these destinations,
effectively excluding these diagnoses. Dengue fever is compatible with her illness,
and this diagnosis will be discussed later.
Typhoid fever is a possible bacterial diagnosis and has been reported in travelers
returning from Haiti [37]. She was, however, both careful about her food and water
ingestion and was vaccinated. Although typhoid vaccination does not guarantee
protection, its administration makes the diagnosis much less likely. In addition, her
rash was more extensive than the faint abdominal rash seen occasionally with
typhoid; however, this disease should still be ruled out by obtaining blood and stool
cultures.
Her illness has many features consistent with leptospirosis, but the rash was
atypical, she did not have any associated renal abnormalities, and she had no obvious
exposure to animals nor had she been swimming in contaminated water. Rickettsia
could also cause her symptoms, particularly murine and epidemic typhus, since both
of these are associated with a truncal rash, fever, headache, and malaise and do not
have an eschar at the site of the bite [23,24]. Although her illness was compatible
with a rickettsial infection, the rash with rickettsiae often occurs after several days of
fever, and disease is most frequently seen with crowded living conditions, where an
individual is exposed to fleas and rodents for murine typhus and lice for epidemic
typhus. Diagnosis is generally made by serology. If other diagnoses were not
forthcoming, an empiric course oftetracycline might be considered.
The remaining diagnosis of dengue fever was most consistent with her clinical
picture. The incubation period was short, and her geographic exposure was in Haiti,
an island known to be endemic for dengue. The Caribbean has seen an increase in
dengue fever over the last decade. She also had noted frequent exposure to
mosquitoes, the vector ofdengue fevervirus. Her dengue virus serology was positive;
antibodies to group 1 went from negative to 1:128, group 2 from negative to 1:8, and
group 4 from 1:8 to 1:256. Results ofher blood and stool cultures were negative, and
two malaria smears were also negative.
Twenty to 50 serologically confirmed cases of dengue fever are seen annually in
travelers returning to the United States, and in recent years autochthonous cases
have evenoccurred in the United States [22,38]. Her symptoms ofthe abrupt onset of
fever, chills, headaches, and severe myalgias, with nausea and vomiting are typical.
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The rash was appropriately distributed, and her leukopenia and mildly elevated liver
enzymes were characteristic of dengue. All of these findings fit the picture ofclassic
dengue fever. More severe illness with dengue virus may occur, such as dengue
hemorrhagic fever and dengue shock syndrome. These illnesses frequently affect
children in endemic areas and are associated with a repeated infection with another
dengue virus serotype. Immune mechanisms appear to enhance an inflammatory
response to the virus, leading to thrombocytopenia, a coagulopathy, and vascular
instability [39,40]. She did have mild thrombocytopenia on repeat testing (104,000
platelets), but at no time did she have either petechiae or a coagulopathy.
Treatment of classic dengue fever is supportive, with resolution of the illness
spontaneously over several days. Some patients may have a mild relapse, and others
are left with a prolonged convalescence, often associated with feelings ofdepression
and fatigue. In this case, the patient resolved her illness over the subsequent week
with supportive therapy.
SUMMARY
Recognition of clinical syndromes in returning travelers is an important part of
providing care to international travelers. Taking a historywith attention to pre-travel
preventive measures, the patient's itinerary, and potential exposures is particularly
important. Examining the patient to look for obvious physical signs and then
obtaining basic laboratory data will provide most physicians with the necessary
information to generate a differential diagnosis. These diagnoses can be matched
against the incubation period of the disease, the geographic location of illness, the
frequency of illness in returned travelers, and the pre-travel preventive measures.
Careful attention to these aspects of patient care should result in the appropriate
diagnosis and therapeutic intervention for the returned traveler.
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